iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Main Management LLC

Main Management LLC reduced its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 33.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 300 shares of the financial services provider’s stock after selling 152 shares during the quarter. Main Management LLC’s holdings in iShares Biotechnology ETF were worth $40,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of IBB. HHM Wealth Advisors LLC grew its holdings in shares of iShares Biotechnology ETF by 200.0% in the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares during the period. VSM Wealth Advisory LLC acquired a new position in iShares Biotechnology ETF in the 4th quarter valued at about $30,000. Bradley & Co. Private Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $32,000. Newbridge Financial Services Group Inc. acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in shares of iShares Biotechnology ETF during the 4th quarter worth approximately $34,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

IBB opened at $119.53 on Wednesday. The stock has a market capitalization of $5.23 billion, a PE ratio of 25.09 and a beta of 0.84. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $150.57. The business’s 50 day moving average price is $124.77 and its 200 day moving average price is $133.19.

iShares Biotechnology ETF Increases Dividend

The firm also recently announced a dividend, which was paid on Friday, March 21st. Shareholders of record on Tuesday, March 18th were given a $0.1212 dividend. The ex-dividend date of this dividend was Tuesday, March 18th. This is an increase from iShares Biotechnology ETF’s previous dividend of $0.06.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.